Engaging patients in their care is often touted as a surefire way to control costs and reduce utilization of services, but new research calls that assumption into question.
Armed with eight years of survey data from more than 20,000 patients, researchers from the University of Chicago argue that shared decisionmaking may actually result in increased inpatient spending and longer lengths of stay.
Read the full story here: http://bit.ly/11uBHNI
Source: Modern Healthcare
“Lots of people, including me, believe that engaging patients will improve health outcomes and satisfaction,” Dr. David Meltzer, chief of hospital medicine and an associate professor of economics and public policy at the University of Chicago, and a co-author of the study, said in an interview. “People have extended that idea to mean that it also lowers costs, and that's not so clear.”
According to the study, published today by JAMA Internal Medicine, patients who indicated a strong preference for involved decisionmaking—based on their level of agreement with the statement, “I prefer to leave decisions about my care up to my doctor”—incurred healthcare costs that were 6% higher, or an average of $865 more per hospital stay. Their lengths of stay were also about 5% longer.
AI Meets Medicare: Inside CMS’s WISeR Model With Sanjay Doddamani, MD, MBA, Part 2
August 5th 2025In this second part of his interview with The American Journal of Managed Care®, Sanjay Doddamani, MD, MBA, a former senior advisor to CMMI and founder and CEO of Guidehealth, continues a dialogue on the future of value-based care and the promise—and limits—of AI-enabled innovation, reflecting on challenges like rising Medicare costs and patients’ growing financial burdens.
Read More
Trump Directs Pharma Companies on Cutting Drug Prices Under Most-Favored-Nation Order
July 31st 2025President Donald Trump has sent letters to pharmaceutical companies, aiming to compel them to lower drug prices in the US to match the lowest prices offered in other developed nations, a move that could significantly reduce costs and disrupt the current system of pharmacy benefit managers.
Read More
AI Meets Medicare: Inside CMS’s WISeR Model With Sanjay Doddamani, MD, MBA, Part 2
August 5th 2025In this second part of his interview with The American Journal of Managed Care®, Sanjay Doddamani, MD, MBA, a former senior advisor to CMMI and founder and CEO of Guidehealth, continues a dialogue on the future of value-based care and the promise—and limits—of AI-enabled innovation, reflecting on challenges like rising Medicare costs and patients’ growing financial burdens.
Read More
Trump Directs Pharma Companies on Cutting Drug Prices Under Most-Favored-Nation Order
July 31st 2025President Donald Trump has sent letters to pharmaceutical companies, aiming to compel them to lower drug prices in the US to match the lowest prices offered in other developed nations, a move that could significantly reduce costs and disrupt the current system of pharmacy benefit managers.
Read More
2 Commerce Drive
Cranbury, NJ 08512